Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.

Leopold, W R

Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia. [electronic resource] - NCI monographs : a publication of the National Cancer Institute 1987 - 99-104 p. digital

Publication Type: Journal Article

0893-2751


Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Drug Synergism
Fluorouracil--administration & dosage
Leukemia P388--drug therapy
Leukemia, Experimental--drug therapy
Mice
Quinazolines--administration & dosage
Thioguanine--administration & dosage
Trimetrexate
Vincristine--administration & dosage